all report title image

RABIES ANTISERUM MARKET ANALYSIS

Rabies Antiserum Market, By Type (Monoclonal Antibodies (mAbs), Polyclonal Antibodies), By Application (Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Mar 2025
  • Code : CMI5711
  • Pages :155
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market News

Recent Developments

New product launches

  1. In April 2020, Grifols, a leading global producer of plasma-derived medicines, announced the launch of a new 3-mL (900-IU) vial for HyperRAB (rabies immune globulin [human]), a treatment for rabies postexposure prophylaxis.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.